Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon

M. Lisker-Melman, D. Webb, A. M. Di Bisceglie, C. Kassianides, Paul Martin, V. Rustgi, J. G. Waggoner, Y. Park, J. H. Hoofnagle

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

A high proportion of patients with HBV-related glomerulonephritis will respond to a 4-month course of alpha-interferon with a clinical, biochemical, and serologic remission.

Original languageEnglish
Pages (from-to)479-483
Number of pages5
JournalAnnals of Internal Medicine
Volume111
Issue number6
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Chronic Hepatitis B
Virus Diseases
Glomerulonephritis
Hepatitis B virus
Interferon-alpha
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lisker-Melman, M., Webb, D., Di Bisceglie, A. M., Kassianides, C., Martin, P., Rustgi, V., ... Hoofnagle, J. H. (1989). Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Annals of Internal Medicine, 111(6), 479-483.

Glomerulonephritis caused by chronic hepatitis B virus infection : Treatment with recombinant human alpha-interferon. / Lisker-Melman, M.; Webb, D.; Di Bisceglie, A. M.; Kassianides, C.; Martin, Paul; Rustgi, V.; Waggoner, J. G.; Park, Y.; Hoofnagle, J. H.

In: Annals of Internal Medicine, Vol. 111, No. 6, 01.01.1989, p. 479-483.

Research output: Contribution to journalArticle

Lisker-Melman, M, Webb, D, Di Bisceglie, AM, Kassianides, C, Martin, P, Rustgi, V, Waggoner, JG, Park, Y & Hoofnagle, JH 1989, 'Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon', Annals of Internal Medicine, vol. 111, no. 6, pp. 479-483.
Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V et al. Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon. Annals of Internal Medicine. 1989 Jan 1;111(6):479-483.
Lisker-Melman, M. ; Webb, D. ; Di Bisceglie, A. M. ; Kassianides, C. ; Martin, Paul ; Rustgi, V. ; Waggoner, J. G. ; Park, Y. ; Hoofnagle, J. H. / Glomerulonephritis caused by chronic hepatitis B virus infection : Treatment with recombinant human alpha-interferon. In: Annals of Internal Medicine. 1989 ; Vol. 111, No. 6. pp. 479-483.
@article{3b9ace16de424e0a9662be55969ea805,
title = "Glomerulonephritis caused by chronic hepatitis B virus infection: Treatment with recombinant human alpha-interferon",
abstract = "A high proportion of patients with HBV-related glomerulonephritis will respond to a 4-month course of alpha-interferon with a clinical, biochemical, and serologic remission.",
author = "M. Lisker-Melman and D. Webb and {Di Bisceglie}, {A. M.} and C. Kassianides and Paul Martin and V. Rustgi and Waggoner, {J. G.} and Y. Park and Hoofnagle, {J. H.}",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "111",
pages = "479--483",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "6",

}

TY - JOUR

T1 - Glomerulonephritis caused by chronic hepatitis B virus infection

T2 - Treatment with recombinant human alpha-interferon

AU - Lisker-Melman, M.

AU - Webb, D.

AU - Di Bisceglie, A. M.

AU - Kassianides, C.

AU - Martin, Paul

AU - Rustgi, V.

AU - Waggoner, J. G.

AU - Park, Y.

AU - Hoofnagle, J. H.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A high proportion of patients with HBV-related glomerulonephritis will respond to a 4-month course of alpha-interferon with a clinical, biochemical, and serologic remission.

AB - A high proportion of patients with HBV-related glomerulonephritis will respond to a 4-month course of alpha-interferon with a clinical, biochemical, and serologic remission.

UR - http://www.scopus.com/inward/record.url?scp=0024447367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024447367&partnerID=8YFLogxK

M3 - Article

C2 - 2774373

AN - SCOPUS:0024447367

VL - 111

SP - 479

EP - 483

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 6

ER -